课题基金 / 基金详情

项目摘要

项目成果

HOLLY VAN REMMEN的其他基金

相似基金

相关文献

中文摘要
翻译
我们正在申请资金,以支持美国老龄协会(AGE)第51届年会 将于2023年6月5日至10日在俄克拉何马城举行。第51届AGE年会将与 与Nathan Shock Center在衰老基础生物学方面的卓越中心座谈会(6月6日)。从它的第一个 自1971年召开会议以来,美国老龄协会一直是美国唯一的科学协会 只专注于衰老的生物学。一年一度的老年会议是#年的主要会议之一。 生物老年学研究,并作为一个关键机制,年龄推进其使命促进 生物医学老化研究,旨在延长人类的功能寿命,让公众了解情况 ,以增加医护人员对生物老年学的认识,并促进 年龄学员和科学成员的科学和专业职业发展。的主要目标是 会议是将资深和初级科学家召集在一个论坛上,在那里研究衰老的最新发现 讨论和辩论,以突出该领域令人兴奋的新研究,并促进新的 参与者之间的想法和协作活动。AGE第51届年会的主题是 老龄化研究的发展--过去和现在如何指引我们走向未来“。受邀的演讲者包括 杰出的知名科学家、早期职业调查人员和实习生,所有这些人都将根据 他们的科学的质量和影响。我们已经计划了9个非竞争的口头会议,将与之一起举行 有三个专题讲座,其中一个将向公众开放。培养下一代 生物老年学家是该协会的主要目标;因此,将组织一次完整的会议。 由实习生年龄分会。此外,我们选择在每届会议上有两名发言者,作为 从提交的摘要中挑选的早期职业调查人员或实习生。计划举行两次海报会议, 不会与口头陈述竞争。摘要将被审查和评分,排名前40位的海报演示者 将有机会在两分钟的口头“海报推销”期间展示他们的海报 会话。将实现性别平等,约50%的演讲者将是职业生涯早期或实习生 我们将至少有20%的人来自代表不足的少数群体。4.我们期待着会议的召开 身临其境地观看现场直播的虚拟组件。。AGE在完全虚拟和混合方面都有经验 会议,并将准备在需要时改用完全虚拟的格式。我们将坚持 既定的会议指导方针,包括确保提供日托机会和有特殊需要的人员 如果是这样的话。
英文摘要
We are requesting funds to support the 51st Annual Meeting of the American Aging Association (AGE) that will take place on June 5-10, 2023 in Oklahoma City, OK. The 51st Annual AGE Meeting will be held in conjunction with a Nathan Shock Centers of Excellence in the Basic Biology of Aging Symposium (June 6). Since its first conference in 1971, the American Aging Association has been the only scientific society in the United States focused solely on the biology of aging. The annual AGE meeting is one of the premier meetings in biogerontological research and serves as a critical mechanism by which AGE advances its mission to promote biomedical aging studies that target increasing the functional life span of humans, to keep the public informed on these activities, to increase knowledge of biogerontology among health care professionals, and to foster the scientific and professional career development of AGE trainees and scientific members. The primary goal of the conference is to convene senior and junior scientists in a forum where the latest discoveries in aging research are discussed and debated, to highlight exciting new research in the field, and to promote the emergence of new ideas and collaborative activities among participants. The theme for the AGE 51st annual meeting is “The Evolution of Aging Research –How the Past and Present Direct Us to the Future”. The invited speakers include prominent established scientists, early career investigators, and trainees, all of whom will be selected based on the quality and impact of their science. We have planned 9 non-competing oral sessions that will be held along with three special lectures, one of which will be open to the general public. Fostering the next generation of biogerontologists is a primary goal of the society; therefore, one of the sessions will be organized in its entirety by the Trainee Chapter of AGE. In addition, we have chosen to have two speakers in each of the sessions as early career investigators or trainees selected from submitted abstracts. Two poster sessions are planned that will not compete with oral presentations. Abstracts will be reviewed and scored and the top 40 poster presenters will be given the opportunity to present their posters in a two-minute oral “poster pitch” during the regular sessions. Gender parity will be achieved and approximately 50% of all speakers will be early career or trainees and we will have at least 20% from underrepresented minority groups. We expect that the meeting will be held in person with a live-streamed virtual component. . AGE has experience with both fully virtual and hybrid meetings, and will be prepared to switch to an entirely virtual format if the need arises. We will adhere to established meeting guidelines, including ensuring that day care opportunities and special need access are provided.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging
Testing OKN-007 as a potential intervention for ALS
  • 批准号:
    10513312
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    HOLLY VAN REMMEN
  • 依托单位:
Testing OKN-007 as a potential intervention for ALS
  • 批准号:
    10259079
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    HOLLY VAN REMMEN
  • 依托单位:
海外基金